Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Tirzepatide is a once-weekly injection used for adults who are considered obese or overweight
Metabolic syndrome is characterised by insulin resistance and consequent hyperinsulinaemia - hyperinsulinaemia is associated with increased appetite and consequent weight gain which then compounds the insulin resistance
Contacts Partner Brussels D | +32.2.282.1843 Insights Publication | 07.30.26 Publication | 07.28.26
Product Attributes Customization Available Certification MSDS, GMP Age Group Adults Model NO
Based on the dramatic fat reduction (up to 82.4%) and enzyme normalization (70-80%), researchers estimate a high probability of NASH resolution, but this needs confirmation in a dedicated Phase 3 trial with biopsy endpoints (expected 2027-2030)
US$ 26.21
US$ 26.94
US$ 24.42
US$ 24.32
US$ 25.91
US$ 25.08
US$ 24.02
:max_bytes(150000):strip_icc()/rs-the-ordinary-copper-peptides-serum-tout-caf2cd9e207649e7bdcd8c0a68890047.jpg)
